Investor Relations

Investor Relations Newsroom

Newsroom

Date	Title
08/08/19	HC2 Holdings Reports Second Quarter 2019 Results
07/31/19	Pansend Life Sciences’ Portfolio Company MediBeacon Announces $30 Million Investment from Huadong Medicine and Exclusive Commercialization Partnership in Greater China
07/25/19	HC2 Holdings to Announce Second Quarter 2019 Financial Results
07/25/19	HC2 Holdings to Announce Second Quarter 2019 Financial Results
06/17/19	HC2 Portfolio Company American Natural Gas Acquires ampCNG
06/13/19	Pansend Life Sciences’ Portfolio Company, R2 Dermatology, Enters Into Exclusive China/Asia-Pacific Distribution Agreement
06/13/19	R2 Dermatology Announces Signing of Exclusive Asia-Pacific Distribution Agreement with China’s Huadong Medicine Company Limited
05/07/19	DBM Global Inc., a HC2 Portfolio Company, to Pay Cash Dividend
05/07/19	HC2 Holdings Reports First Quarter 2019 Results
04/23/19	HC2 Holdings to Announce First Quarter 2019 Financial Results

Investor Relation Subsidiary Newsroom

There are currently no news releases.

Print Page

Print Page |

E-mail Page

E-mail Page |

RSS Feeds |

E-mail Alert/s

E-mail Alerts |

IR Contacts

IR Contacts